| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Kylo-11 | Kylo-11; Kylo11 | Phase 2 Clinical | Shanghai Hejiya Biopharmaceutical Co Ltd, Xiamen Ganbaoli Biopharmaceutical Co Ltd | Atherosclerosis; Cardiovascular Diseases; Hyperlipoproteinemias; Lipid Metabolism Disorders | Details |
